Humana forecast annual profit below Wall Street estimates on Tuesday as it anticipates a greater-than-expected decline in its ...
Humana will make investments to improve its Medicare Advantage Star Ratings, Chief Financial Officer Celeste Mellet said.
Barclays analyst Andrew Mok raised the firm’s price target on Humana (HUM) to $270 from $255 and keeps an Equal Weight rating on the shares.
The dip came after Humana released its 2024 end of year and fourth quarter earnings, which projected an annual profit of ...
Humana posted a $693 million loss in the fourth quarter of 2024, a notable increase from its $541 million loss in the ...
Shares of health insurance company Humana (NYSE:HUM) fell 8.2% in the afternoon session after the company reported mixed ...
Humana Inc. (NYSE:HUM) posted a fourth-quarter adjusted EPS loss of $(2.16), down from $(0.11) a year ago, in line with the ...
Expects individual Medicare Advantage annual membership decline of approximately 550,000, or approximately 10 percent, from 2024, inclusive of ...
Humana Inc.’s stock fell 5.6% Tuesday, after the health insurer and managed-care company’s quarterly loss widened. The ...